NDC 71335-1313

Gabapentin

Gabapentin

Gabapentin is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Bryant Ranch Prepack. The primary component is Gabapentin.

Product ID71335-1313_9974e2f5-d748-40de-b55d-fd5fe28715bb
NDC71335-1313
Product TypeHuman Prescription Drug
Proprietary NameGabapentin
Generic NameGabapentin
Dosage FormCapsule
Route of AdministrationORAL
Marketing Start Date2018-05-14
Marketing CategoryANDA / ANDA
Application NumberANDA206943
Labeler NameBryant Ranch Prepack
Substance NameGABAPENTIN
Active Ingredient Strength400 mg/1
Pharm ClassesAnti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 71335-1313-0

180 CAPSULE in 1 BOTTLE (71335-1313-0)
Marketing Start Date2022-02-09
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 71335-1313-8 [71335131308]

Gabapentin CAPSULE
Marketing CategoryANDA
Application NumberANDA206943
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2018-05-14

NDC 71335-1313-4 [71335131304]

Gabapentin CAPSULE
Marketing CategoryANDA
Application NumberANDA206943
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2018-05-14

NDC 71335-1313-6 [71335131306]

Gabapentin CAPSULE
Marketing CategoryANDA
Application NumberANDA206943
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2018-05-14

NDC 71335-1313-9 [71335131309]

Gabapentin CAPSULE
Marketing CategoryANDA
Application NumberANDA206943
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2018-05-14

NDC 71335-1313-1 [71335131301]

Gabapentin CAPSULE
Marketing CategoryANDA
Application NumberANDA206943
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2018-05-14

NDC 71335-1313-3 [71335131303]

Gabapentin CAPSULE
Marketing CategoryANDA
Application NumberANDA206943
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2018-05-14

NDC 71335-1313-2 [71335131302]

Gabapentin CAPSULE
Marketing CategoryANDA
Application NumberANDA206943
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2018-05-14

NDC 71335-1313-7 [71335131307]

Gabapentin CAPSULE
Marketing CategoryANDA
Application NumberANDA206943
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2018-05-14

NDC 71335-1313-0 [71335131300]

Gabapentin CAPSULE
Marketing CategoryANDA
Application NumberANDA206943
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2018-05-14

NDC 71335-1313-5 [71335131305]

Gabapentin CAPSULE
Marketing CategoryANDA
Application NumberANDA206943
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2018-05-14

Drug Details

Active Ingredients

IngredientStrength
GABAPENTIN400 mg/1

OpenFDA Data

SPL SET ID:01b810b7-f4c8-4412-bbc5-b9220d8770d8
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 310432
  • 310431
  • 310430

    • Pharmacological Class

    • Anti-epileptic Agent [EPC]
    • Decreased Central Nervous System Disorganized Electrical Activity [PE]
    • Anti-epileptic Agent [EPC]
    • Decreased Central Nervous System Disorganized Electrical Activity [PE]

    NDC Crossover Matching brand name "Gabapentin" or generic name "Gabapentin"

    NDCBrand NameGeneric Name
    0093-4443GabapentinGabapentin
    0093-4444GabapentinGabapentin
    0143-3991GabapentinGabapentin
    0143-3993GabapentinGabapentin
    0143-3994GabapentinGabapentin
    0143-9992GabapentinGabapentin
    0143-9993GabapentinGabapentin
    0143-9994GabapentinGabapentin
    67877-222GabapentinGabapentin
    67877-223GabapentinGabapentin
    67877-224GabapentinGabapentin
    67877-428GabapentinGabapentin
    67877-429GabapentinGabapentin
    68001-006GabapentinGabapentin
    68001-007GabapentinGabapentin
    68071-1212GABAPENTINGABAPENTIN
    68071-1292GabapentinGabapentin
    68071-1808GABAPENTINGABAPENTIN
    68071-1907GABAPENTINGABAPENTIN
    68071-1995GabapentinGabapentin
    68071-3230GABAPENTINGABAPENTIN
    68071-3046GabapentinGabapentin
    68071-3244GabapentinGabapentin
    68071-4087GabapentinGabapentin
    68071-3086GABAPENTINGABAPENTIN
    68071-3383GABAPENTINGABAPENTIN
    68071-3314GABAPENTINGABAPENTIN
    68071-4049GABAPENTINGABAPENTIN
    68071-4241GABAPENTINGABAPENTIN
    68071-4099GabapentinGabapentin
    68071-4113GabapentinGabapentin
    68071-4292GabapentinGabapentin
    68071-4180GabapentinGabapentin
    68071-4090GabapentinGabapentin
    68071-4329GabapentinGabapentin
    68071-4603GabapentinGabapentin
    68071-4169GabapentinGabapentin
    68071-4346GabapentinGabapentin
    68071-4366GabapentinGabapentin
    68071-4729GabapentinGabapentin
    68071-4402GABAPENTINGABAPENTIN
    68071-4784GABAPENTINGABAPENTIN
    68084-774GabapentinGabapentin
    68084-783GabapentinGabapentin
    68084-797GabapentinGabapentin
    68084-762GabapentinGabapentin
    0440-5562GABAPENTINGABAPENTIN
    0440-5563GABAPENTINGABAPENTIN
    68084-802GabapentinGabapentin
    68151-1028GabapentinGabapentin
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.